266 related articles for article (PubMed ID: 18703501)
1. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes.
Hilvo M; Baranauskiene L; Salzano AM; Scaloni A; Matulis D; Innocenti A; Scozzafava A; Monti SM; Di Fiore A; De Simone G; Lindfors M; Jänis J; Valjakka J; Pastoreková S; Pastorek J; Kulomaa MS; Nordlund HR; Supuran CT; Parkkila S
J Biol Chem; 2008 Oct; 283(41):27799-27809. PubMed ID: 18703501
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX.
Alterio V; Hilvo M; Di Fiore A; Supuran CT; Pan P; Parkkila S; Scaloni A; Pastorek J; Pastorekova S; Pedone C; Scozzafava A; Monti SM; De Simone G
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16233-8. PubMed ID: 19805286
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
De Simone G; Supuran CT
Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
[TBL] [Abstract][Full Text] [Related]
4. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors.
Innocenti A; Pastorekova S; Pastorek J; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2009 Oct; 19(20):5825-8. PubMed ID: 19751975
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase IX as a target for designing novel anticancer drugs.
Monti SM; Supuran CT; De Simone G
Curr Med Chem; 2012; 19(6):821-30. PubMed ID: 22214452
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR.
Ciani L; Cecchi A; Temperini C; Supuran CT; Ristori S
J Phys Chem B; 2009 Oct; 113(42):13998-4005. PubMed ID: 19778001
[TBL] [Abstract][Full Text] [Related]
8. Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX.
Hulikova A; Zatovicova M; Svastova E; Ditte P; Brasseur R; Kettmann R; Supuran CT; Kopacek J; Pastorek J; Pastorekova S
FEBS Lett; 2009 Nov; 583(22):3563-8. PubMed ID: 19861127
[TBL] [Abstract][Full Text] [Related]
9. The catalytic properties of murine carbonic anhydrase VII.
Earnhardt JN; Qian M; Tu C; Lakkis MM; Bergenhem NC; Laipis PJ; Tashian RE; Silverman DN
Biochemistry; 1998 Jul; 37(30):10837-45. PubMed ID: 9692974
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX (CA IX) mediates tumor cell interactions with microenvironment.
Zavadova Z; Zavada J
Oncol Rep; 2005 May; 13(5):977-82. PubMed ID: 15809767
[TBL] [Abstract][Full Text] [Related]
11. Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX.
Leitans J; Kazaks A; Balode A; Ivanova J; Zalubovskis R; Supuran CT; Tars K
J Med Chem; 2015 Nov; 58(22):9004-9. PubMed ID: 26522624
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides.
Pastorekova S; Vullo D; Casini A; Scozzafava A; Pastorek J; Nishimori I; Supuran CT
J Enzyme Inhib Med Chem; 2005 Jun; 20(3):211-7. PubMed ID: 16119190
[TBL] [Abstract][Full Text] [Related]
13. The catalytic properties of human carbonic anhydrase IX.
Wingo T; Tu C; Laipis PJ; Silverman DN
Biochem Biophys Res Commun; 2001 Nov; 288(3):666-9. PubMed ID: 11676494
[TBL] [Abstract][Full Text] [Related]
14. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
Ozensoy Guler O; Arslan O; Kockar F
Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors.
Ditte P; Dequiedt F; Svastova E; Hulikova A; Ohradanova-Repic A; Zatovicova M; Csaderova L; Kopacek J; Supuran CT; Pastorekova S; Pastorek J
Cancer Res; 2011 Dec; 71(24):7558-67. PubMed ID: 22037869
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.
Franchi M; Vullo D; Gallori E; Pastorek J; Russo A; Scozzafava A; Pastorekova S; Supuran CT
J Enzyme Inhib Med Chem; 2003 Aug; 18(4):333-8. PubMed ID: 14567548
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX.
Zat'ovicová M; Tarábková K; Svastová E; Gibadulinová A; Mucha V; Jakubícková L; Biesová Z; Rafajová M; Ortova Gut M; Parkkila S; Parkkila AK; Waheed A; Sly WS; Horak I; Pastorek J; Pastoreková S
J Immunol Methods; 2003 Nov; 282(1-2):117-34. PubMed ID: 14604546
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 Dec; 46(25):5471-7. PubMed ID: 14640555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
